Keyphrases
Natural Killer Cells
100%
Antitumor Activity
40%
Induced Pluripotent Stem Cells (iPSCs)
26%
Stem Cell-derived
26%
Tumor Control
23%
T Cells
22%
AT-rich
20%
Rich Interaction
20%
Glycogen Synthase Kinase 3 (GSK3)
20%
Metabolic Programming
20%
Interaction Domains
20%
Cytotoxicity
20%
Lymphoma
20%
Multi-antigen
20%
Antigen Targeting
20%
Antigen Escape
20%
Leukemia
20%
Durable Response
20%
Multiple Myeloma
20%
CD57
13%
Adoptive Transfer
12%
Antibody-dependent Cellular Cytotoxicity
9%
Chimeric Antigen Receptor T Cells (CAR-T)
9%
Programmed Death-ligand 1 (PD-L1)
8%
Mitochondrial Membrane Potential
8%
Interleukin-15 (IL-15)
6%
Interferon-γ
6%
Xenogeneic
6%
CD16
6%
Cleavable
6%
High Affinity
6%
Antigen Heterogeneity
5%
Antigen Loss
5%
B-cell Malignancies
5%
Therapeutic Antibody
5%
CD19
5%
Antibody Targeting
5%
Immunology and Microbiology
Natural Killer Cell
80%
Antineoplastic Activity
40%
Induced Pluripotent Stem Cell
26%
Cytotoxicity
25%
T Cell
22%
Maturation
20%
Multiple Myeloma
20%
CD19
14%
Chimeric Antigen Receptor
9%
Antibody-Dependent Cell-Mediated Cytotoxicity
8%
B Cell
8%
CD38
6%
CD16
6%
Interleukin 15
6%
Therapeutic Antibodies
5%
Tumor Necrosis Factor
5%
Medicine and Dentistry
Natural Killer Cell
60%
Induced Pluripotent Stem Cell
26%
T Cell
22%
Cytotoxicity
22%
Antineoplastic Activity
20%
Neoplasm
20%
Multiple Myeloma
20%
Leukemia
20%
Adoptive Transfer
9%
Chimeric Antigen Receptor
9%
Cancer
9%
Antibody Dependent Cellular Cytotoxicity
6%
Interleukin 15
6%
B Cell
5%
